Lupus Cost Regression Analysis

Project: Research

Project Description

As requested by GSK, we have agreed to use our existing lupus cost data to prepare cost regression modelling report in line with GSK internal costing procedures.
StatusActive
Effective start/end date17/12/1816/12/20

Funding

  • GlaxoSmithKline (GSK) AUS : AUD90,858.74